Drug profile · INN
calaspargase pegol-mknl
ASPARLAS
calaspargase pegol-mknl (ASPARLAS) is a asparagine hydrolytic enzyme. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — calaspargase pegol-mknl
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
calaspargase pegol-mknl (ASPARLAS) is a asparagine hydrolytic enzyme. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Asparagine hydrolytic enzyme
Primary target: Asparagine
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is calaspargase pegol-mknl?
calaspargase pegol-mknl (ASPARLAS) is a asparagine hydrolytic enzyme. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for calaspargase pegol-mknl?
ASPARLAS is a marketed brand name for calaspargase pegol-mknl. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calaspargase pegol-mknl?
calaspargase pegol-mknl has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.